Formycon rises on FYB206 trial progress, stays in lead on Keytruda biosimilar
Formycon rises on FYB206 trial progress, stays in lead on Keytruda biosimilarSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com
Formycon rises on FYB206 trial progress, stays in lead on Keytruda biosimilarSource: Investing.com

MP Materials soars on multibillion-dollar deal with US Defense DepartmentSource: Investing.com

MP Materials partners with Department of Defense to boost US rare earth magnet supply, shares soarSource: Reuters

EU code of practice to help firms with AI rules will focus on copyright, safetySource: Reuters

Judge to weigh blocking Trump on birthright citizenship despite Supreme Court rulingSource: Reuters

Ex-Goldman partner's investment firm issues $1 billion in homebuilder loansSource: Reuters
Goldman gives "buy" rating to Nvidia, citing signs of early AI monetizationSource: Investing.com

Jet2 shares backed by Jefferies and RBC amid weakness; 21% upside seenSource: Investing.com

ITV and Disney to share shows on streaming platformsSource: Investing.com

Pakistan eyes $1 billion valuation in Roosevelt Hotel redevelopment plan, source saysSource: Reuters